Company registration number 07737739 (England and Wales)
THE GEOGHEGAN GROUP (SURREY) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
Kings House
9-10 Haymarket
London
United Kingdom
SW1Y 4BP
THE GEOGHEGAN GROUP (SURREY) LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Statement of changes in equity
Notes to the financial statements
4 - 13
THE GEOGHEGAN GROUP (SURREY) LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr A. Geoghegan
Mr C. Geoghegan
Mr P. Geoghegan
Company number
07737739
Registered office
The Old Surgery
The Green
Ewhurst
Cranleigh
Surrey
United Kingdom
GU6 7RP
Auditor
TC Group London Limited
Kings House
9-10 Haymarket
London
United Kingdom
SW1Y 4BP
THE GEOGHEGAN GROUP (SURREY) LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 2 -
2025
2024
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
5
5,610,480
5,364,019
Investments
4
402,600
393,580
6,013,080
5,757,599
Current assets
Debtors
6
3,848,436
3,736,969
Cash at bank and in hand
888,223
1,602,682
4,736,659
5,339,651
Creditors: amounts falling due within one year
7
(8,839,123)
(7,801,066)
Net current liabilities
(4,102,464)
(2,461,415)
Total assets less current liabilities
1,910,616
3,296,184
Provisions for liabilities
(7,182)
(7,182)
Net assets
1,903,434
3,289,002
Capital and reserves
Called up share capital
2,500
2,500
Profit and loss reserves
1,900,934
3,286,502
Total equity
1,903,434
3,289,002
THE GEOGHEGAN GROUP (SURREY) LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 3 -

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 22 December 2025 and are signed on its behalf by:
Mr A. Geoghegan
Director
Company Registration No. 07737739
The notes on pages 4 to 13 form part of these financial statements
THE GEOGHEGAN GROUP (SURREY) LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 4 -
1
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

In the opinion of the directors there are no significant judgements or areas of estimation uncertainty other than those disclosed in the prior period adjustment note 12.

2
Accounting policies
Company information

The Geoghegan Group (Surrey) Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Old Surgery, The Green, Ewhurst, Cranleigh, Surrey, United Kingdom, GU6 7RP.

2.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies' regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

 

The Geoghegan Group (Surrey) Limited is a wholly owned subsidiary of Geoghegan Holdings Limited and the results of The Geoghegan Group (Surrey) Limited are included in the consolidated financial statements of Geoghegan Holdings Limited which are available from The Old Surgery, The Green, Ewhurst, Cranleigh, Surrey, GU6 7RP.

2.2
Turnover

The turnover in the profit and loss account represents amounts invoiced during the year for services provided in the year.

THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
2
Accounting policies
(Continued)
- 5 -
2.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

2.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
not depreciated
Fixtures, fittings and equipment
over 3 years
Motor vehicles
over 5 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

2.5
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

2.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible fixed assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
2
Accounting policies
(Continued)
- 6 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

2.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors, cash and bank balances and loans due from group companies, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

2.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
2
Accounting policies
(Continued)
- 7 -
2.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

2.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
10
9
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
402,600
402,550
Loans to group undertakings and participating interests
-
0
(8,970)
402,600
393,580
Movements in fixed asset investments
Shares in subsidiaries and associates
Loans to associates
Total
£
£
£
Cost or valuation
At 1 April 2024
402,550
(8,970)
393,580
Valuation changes
50
-
50
Repayments
-
8,970
8,970
At 31 March 2025
402,600
-
402,600
Carrying amount
At 31 March 2025
402,600
-
402,600
At 31 March 2024
402,550
(8,970)
393,580
THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
5
Tangible fixed assets
Freehold land and buildings
Assets under construction
Fixtures, fittings and equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 April 2024
5,341,928
-
0
184,079
70,312
5,596,319
Additions
-
0
260,000
-
0
-
0
260,000
At 31 March 2025
5,341,928
260,000
184,079
70,312
5,856,319
Depreciation and impairment
At 1 April 2024
-
0
-
0
168,771
63,529
232,300
Depreciation charged in the year
-
0
-
0
6,756
6,783
13,539
At 31 March 2025
-
0
-
0
175,527
70,312
245,839
Carrying amount
At 31 March 2025
5,341,928
260,000
8,552
-
0
5,610,480
At 31 March 2024
5,341,928
-
0
15,308
6,783
5,364,019
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Corporation tax recoverable
904,656
890,531
Other debtors
2,868,029
2,821,475
Prepayments and accrued income
75,751
24,963
3,848,436
3,736,969
THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 10 -
7
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
54,826
4,685
Amounts owed to group undertakings
8,163,709
7,238,894
Corporation tax
(9,797)
348,337
Other taxation and social security
12,270
7,592
Other creditors
618,115
201,558
8,839,123
7,801,066
8
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Robert Keen FCCA
Statutory Auditor:
TC Group London Limited
Date of audit report:
22 December 2025
9
Related party transactions

The company has taken advantage of the exemption under section 33.1A of FRS102 from the requirement to disclose transactions with group companies on the grounds that consolidated financial statements are prepared by the ultimate parent company, which are publically available.

10
Directors' transactions

One of the directors maintains a loan account with the company. At the start of the year the director owed the company £2,799,700. During the year the director repaid £37,252. Interest was charged at 3% on the overall overdrawn balance. At the year end the amount owed by the director to the company was £2,762,448.

11
Parent company

The ultimate parent company is Geoghegan Holdings Limited, a company incorporated in England and Wales.

 

The consolidated accounts of the largest group of which the company is a member and for which accounts are prepared can be obtained from the Company Directors, Geoghegan Holdings Limited, The Old Surgery, The Green, Ewhurst, Cranleigh, Surrey, GU6 7RP.

THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 11 -
12
Non-audit services provided by auditor

In common with many businesses of our size and nature we use our auditor to prepare and submit returns to the tax authorities and assist with the preparation of the financial statements,

THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 12 -
13
Prior period adjustment
Reconciliation of changes in equity
1 April
31 March
2023
2024
£
£
Adjustments to prior year
Restructuring and Investment Re-statement
(458,492)
(705,638)
Equity as previously reported
3,910,978
3,994,640
Equity as adjusted
3,452,486
3,289,002
Analysis of the effect upon equity
Profit and loss reserves
(458,492)
(705,638)
Reconciliation of changes in profit for the previous financial period
2024
£
Adjustments to prior year
Restructuring and Investment Re-statement
(247,147)
Profit as previously reported
376,330
Profit as adjusted
129,183
Notes to reconciliation
Restructuring and Investment Re-statement

The Company re-acquired 100% control of The Clavadel (Guildford) Co. Limited, a company registered in England, (Company No. 07839214) in June 2024 following the acquisition of the remaining 51% shareholding it did not already own from Vamed Management und Service GmbH, a company registered in Austria (Company No. FN 80736f).

Due to the circumstances of the transaction, which involved the enforcement of a share buy-back clause at nominal value and a subsequent dispute settlement payment, the Directors have applied a policy of Investment Re-statement.

The policy recognises the economic substance that the Company has returned to its original ownership position. The investment in The Clavadel (Guildford) Co. Limited is therefore presented in the financial statements at its original book cost of £100.

THE GEOGHEGAN GROUP (SURREY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
13
Prior period adjustment
(Continued)
- 13 -

Impact of Re-statement

The pre-existing 49% interest and its associated performance since February 2022 were re-stated to their proportionate carrying value (cost). The cumulative net profit impact include prior fair value adjustment and share of profit of associate profits recognised in the Profit and Loss Account, amounting to £705,639, was reversed out of retained earnings to align the investment with its book value and simplify the balance sheet presentation.

Accounting policy adopted

The Directors have determined that the economic substance of this transaction is a Group Reconstruction and the cessation of the joint venture partnership arrangement, rather than a commercial acquisition. Therefore, standard FRS 102, Section 19 (Business Combinations) has not been applied. Furthermore, the standard purchase method would have required the recognition of a Gain on Bargain Purchase in the Profit and Loss Account, which the Directors believe would misrepresent the economic substance of the transaction, which was in effect a costly resolution of a failed joint venture partnership and a subsequent group restructuring.

The re-acquisition is accounted for using Merger Accounting principles by taking the investment back at the carrying value prior to the establishment of the joint venture in 2022.

 

2025-03-312024-04-01falsefalsefalse22 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr A. GeogheganMr C. GeogheganMr P. Geoghegan2025-12-22077377392024-04-012025-03-3107737739bus:Director12024-04-012025-03-3107737739bus:Director22024-04-012025-03-3107737739bus:Director32024-04-012025-03-3107737739bus:RegisteredOffice2024-04-012025-03-31077377392025-03-31077377392024-03-3107737739core:LandBuildingscore:OwnedOrFreeholdAssets2025-03-3107737739core:ConstructionInProgressAssetsUnderConstruction2025-03-3107737739core:FurnitureFittings2025-03-3107737739core:MotorVehicles2025-03-3107737739core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3107737739core:ConstructionInProgressAssetsUnderConstruction2024-03-3107737739core:FurnitureFittings2024-03-3107737739core:MotorVehicles2024-03-3107737739core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3107737739core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3107737739core:CurrentFinancialInstruments2025-03-3107737739core:CurrentFinancialInstruments2024-03-3107737739core:ShareCapital2025-03-3107737739core:ShareCapital2024-03-3107737739core:RetainedEarningsAccumulatedLosses2025-03-3107737739core:RetainedEarningsAccumulatedLosses2024-03-3107737739core:LandBuildingscore:OwnedOrFreeholdAssets2024-04-012025-03-3107737739core:FurnitureFittings2024-04-012025-03-3107737739core:MotorVehicles2024-04-012025-03-31077377392023-04-012024-03-3107737739core:Non-currentFinancialInstruments2025-03-3107737739core:Non-currentFinancialInstruments2024-03-3107737739core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3107737739core:ConstructionInProgressAssetsUnderConstruction2024-03-3107737739core:FurnitureFittings2024-03-3107737739core:MotorVehicles2024-03-31077377392024-03-3107737739core:ConstructionInProgressAssetsUnderConstruction2024-04-012025-03-3107737739bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107737739bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107737739bus:FRS1022024-04-012025-03-3107737739bus:Audited2024-04-012025-03-3107737739bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP